ConductScience.org, home

Paper200333

Human leukemic "null" cell line (NALL-1).

Hiraki S and 6 others. Cancer, 1977. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human leukemic "null" cell line (NALL-1). Papers, record 200333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/200333

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human leukemic "null" cell line (NALL-1).
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2019-06-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hiraki SS
2Miyoshi II
3Kubonishi II
4Matsuda YY
5Nakayama TT
6Kishimoto HH
7Masuji HH

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell LineMajor topic
Leukemia, LymphoidMajor topic
B-Lymphocytes
Chromosomes, Human
Herpesvirus 4, Human
Humans
T-Lymphocytes

Source PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
23,788,110Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy.Cancer Gene Ther2013https://conductscience.org/library/papers/23788110PubMed
11,986,953N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.Leukemia2002https://conductscience.org/library/papers/11986953PubMed
9,738,982Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody.Jpn J Cancer Res1998https://conductscience.org/library/papers/9738982PubMed
6,785,752Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6785752PubMed
6,283,539Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6283539PubMed
3,134,658Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3134658PubMed
2,476,389Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.Immunogenetics1989https://conductscience.org/library/papers/2476389PubMed
750,114Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.Clin Exp Immunol1978https://conductscience.org/library/papers/750114PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/200333

GET https://conductscience.org/api/papers/v1/200333/authors